Elizabeth L Christie

16PUBLICATIONS
191CO-AUTHORS
Predictive and prognostic markersHaematological tumoursCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Solid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Aug 06, 2026
Using polygenic risk scores to refine risk and outcomes in high-grade serous ovarian cancer in Australia.

|Apr 01, 2026
Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Tibor A Zwimpfer, Sian Fereday, Ahwan Pandey

|Nov 19, 2025
Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Dale Garsed, Tibor Zwimpfer, Sian Fereday

|Sep 25, 2025
Exploiting dysregulated iron homeostasis to eradicate persistent high-grade serous ovarian cancer.

Carmelo Cerra, Madeleine R C Tancock, Niko Thio

|Jul 16, 2025
Genome doubling fuels ovarian cancer evolution and immune dysregulation.

Nikki L Burdett, Elizabeth L Christie

|Feb 19, 2025
Immunogenic cryptic peptides dominate the antigenic landscape of ovarian cancer.

Remya Raja, Kiran K Mangalaparthi, Anil K Madugundu

Pageof 3

Frequent Collaborators

9 joint publications

Ahwan Pandey

7 joint publications

Dale W Garsed

7 joint publications

Sian Fereday

5 joint publications

Dinuka Ariyaratne